Having the right arguments for demonstrating health and cost impact of your innovation is essential for success. Our team includes professionally qualified and experienced health economists who can provide comprehensive health economic assessments and evaluations to support your innovation. Health Tech Enterprise provides a range of offerings to ensure you have the right kind of evidence to convince decision makers and provide health economic evaluations and, tailor-made to your requirements at each stage of technology development.

Evidence Synthesis & Literature Reviews

Reviewing the existing body of published work is a key part in planning for your market access strategy and a crucial cornerstone of evidence-based medicine. Full Health Technology Assessments (HTAs) by NICE require a systematic literature review to be part of the submission.

• Systematic Literature Reviews (SLR)
  Considered the gold-standard of reviews, which critically evaluates and interprets all the available study evidence relevant to a particular question. Systematic Literature Reviews form the comprehensive evidence base needed for Health Technology Assessment and are expected by regulators and publishers.
• Pragmatic Literature Review
  Adapts the conventional systematic review process to take into consideration limited time and resources available. It uses a streamlined methodology to accelerate the review process and focuses on finding the right evidence to address urgent issues or to inform data parameters for an early-stage health economic model.
• Meta Analysis & Network Meta Analysis
  Meta analysis uses statistical approaches to combine the results from a collection of studies to answer a specific question. A network meta-analysis is a pairwise meta-analysis to allow comparison of more than two interventions by using direct and indirect evidence. Depending on the quality of the studies available, a meta-analysis can reduce costs by avoiding unnecessary clinical trials.
• Scoping Reviews
  Used to explore the breadth and extent of all the published evidence available, identify key concepts and research gaps in the research to inform objective setting for future research. Rather than extracting and analysing results, this review maps the landscape of available data.

HTA Support & Evidence Appraisal

• HTA submission
  As well as preparing the HTA submission document, we can integrate systematic literature reviews, evidence synthesis and economic modelling into your HTA submission for approval by the regulatory agency
• Critical Appraisal of HTA submissions & research results
  We can perform critical appraisals of your HTA submissions and  your research results to identify areas of uncertainty, potential risks of bias and confounding and provide recommendations on how to address these.
• Review of Reviews
  Reviews and critically appraises the quality of existing systematic literature reviews in a specific field to assess risks of bias, differences in methodologies and the impact this may have had on the findings.

Budget Impact & Cost-effectiveness Analysis

Health Economics & Decision Modelling

To gain market access to the NHS it is essential to quantify properties, effects, costs and impacts of the new health technology. As well as clinical evidence, these need to present the economic evidence and the incremental health benefit which can be achieved in relation to costs as part of a Health Economic Assessment.

HTE can provide a range of Assessments, appropriate to each stage of technology development

• Budget Impact Analysis
  Often used at an early -stage investigation to determine the impact of a technology on a specific budget (e.g. NHS, Health insurance plan). This type of analysis is concerned with assessing the affordability of the technology from the perspective of a designated budget holder.
• Cost-effectiveness Analysis
  A full model assesses the relative cost-effectiveness of the new technology as compared to current care. A CEA provides impact evidence required by NHS and PSS budget holders and is an essential component of a Health Technology Assessment (HTA) application. This type of analysis  models both current and new care pathways for the addressable market population and often includes a systematic literature review to identify data for parameter inputs. The analysis compares the cost in monetary units with outcomes using a generic measure of utility-weighted health outcome (e.g. QALYs) as per the NICE reference case.
• Cost Consequences Analysis
  Alternative to a cost-effectiveness analysis when measures of effect have not yet been quantified. A less prescriptive form of cost-effectiveness analysis, this is often used to strengthen funding applications. The analysis models both current and new care pathways for the addressable market population, comparing costs against discrete categories of outcomes which do not require utility weighting (e.g. presented as monetary savings, health outcomes in natural units or condition-specific outcomes).  Outcomes tend to be presented in a non-aggregated form.
• Visual customer communication tools
  Design of user-friendly visual representations of the outputs from Health Economic Evaluations to communicate the value of your innovation to potential customers and budget holders.
• Environmental Impact Assessment
  To support future development and new technology adoption, the NHS will soon require all applicants to consider and articulate the environmental impact of their products. HTE provide clients with a service that will quantify and effectively communicate the environmental impact of their MedTech innovations.

Read more about our Net Zero service

See our ECONOMICS Case Studies